Endocyte inc (ECYT)
CashFlow / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net loss

-12,607

-11,564

-8,602

-8,564

-23,266

-11,744

-11,488

-11,064

-8,707

-13,962

-10,152

-9,794

-10,001

-10,604

-10,869

-8,080

-5,675

22,356

-3,141

-2,902

-3,041

-8,227

-3,861

-848

-1,239

-5,433

-9,770

-10,754

-12,069

-10,519

-7,188

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

195

199

202

221

232

230

238

240

235

227

217

220

223

219

223

226

219

208

201

185

177

167

144

114

98

76

68

62

68

64

67

Stock-based compensation

1,650

1,444

1,355

1,489

720

827

1,132

1,432

1,340

4,465

2,084

1,699

1,687

1,854

1,679

1,768

1,552

2,457

2,247

1,653

1,735

1,525

1,145

774

741

726

779

614

567

594

183

Loss (gain) on disposal of property and equipment

-12

16

1

7

30

-142

-2

-

-

-

-

-18

8

0

-1

9

-1

0

-2

0

0

-1

0

-

-

-

-

-

-

-

-

Amortization of debt discount

-685

-403

-192

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of bond premium

-

-

-

-162

-45

3

43

63

63

72

195

282

313

375

338

304

494

475

341

350

356

262

277

396

387

163

12

153

77

79

33

Non cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-0

0

-3

77

44

130

142

328

Change in operating assets and liabilities:
Receivables

-78

31

-177

156

15

-150

-22

-20

69

-231

-8

-29

-104

-4

-718

-3,267

-1,462

-633

-126

8,304

-2,614

-1,622

-1,559

-4,328

5,885

-147

0

-

-

-

-

Accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,180

-357

-

-

-

-

Accounts and accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

97

Prepaid expenses and other assets

6,347

1,712

337

-144

263

-637

-396

27

575

-181

95

-351

87

-177

538

-368

-431

-3,241

1,330

-779

-513

-783

60

973

-347

-326

988

149

-24

452

-1,509

Accounts payable

134

-441

863

135

-978

-179

-3

-356

323

327

-546

360

-591

-32

203

297

-2,165

-275

-1,555

4

417

813

-1,622

1,014

329

-885

66

-359

219

134

948

Accrued wages, benefits and other liabilities

2,057

1,489

-1,155

619

-453

635

-814

1,161

-183

85

-1,835

455

502

49

-1,784

-2,552

-3,624

3,559

-306

850

-280

554

212

1,934

2,460

-181

-729

-297

257

816

61

Deferred revenue

-15

-15

-15

-12

-12

-12

-12

-12

-12

-12

-12

-12

-12

-12

-12

-12

-12

-46,550

-13,170

-2,493

-12,998

-12,998

-12,998

-9,472

-7,780

117,010

0

-

-

-

-

Net cash used in operating activities

-15,528

-11,053

-7,705

-6,246

-7,620

-9,308

-10,483

-8,543

-7,586

-8,384

-10,136

-6,351

-7,855

-7,970

-10,040

-4,409

-7,315

-13,894

-16,585

-9,876

-10,505

-15,495

-15,203

-2,725

-5,717

107,760

-10,125

-10,668

-10,598

-9,163

-4,153

Investing activities
Purchases of property and equipment

28

9

5

35

2

14

29

49

198

430

35

85

160

50

44

108

455

272

665

181

173

395

77

236

941

508

176

36

157

23

17

Proceeds from disposal of property and equipment

1

42

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of investments

196,996

83,305

27,703

55,406

30,860

5,480

14,977

25,031

25,991

47,057

41,852

34,534

17,043

1,589

33,113

32,264

5,008

97,024

15,073

15,903

21,686

33,550

53,886

21,867

62,454

138,134

42,747

43,369

42,307

39,994

111,258

Proceeds from sale and maturities of investments

62,500

25,300

23,500

32,500

28,500

45,930

28,000

29,900

41,900

42,200

76,765

25,215

28,032

8,204

26,662

33,131

29,581

7,549

12,039

27,517

19,082

77,465

71,080

22,075

39,028

9,154

93,413

48,697

24,157

66,999

29,998

Proceeds from issuance of subordinated convertible notes, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,590

Net cash provided by (used in) investing activities

-134,524

-57,972

-4,162

-23,375

-14,685

40,435

12,992

4,819

15,710

-5,287

34,876

-9,405

10,828

6,564

-6,495

768

24,117

-89,747

-3,698

11,433

-2,777

43,519

17,116

-28

-24,367

-129,488

50,488

5,291

-18,307

26,981

-81,277

Stock repurchase

0

-0

104

0

0

1

92

6

-0

49

108

0

-0

0

57

0

3

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock in connection with equity offering

188,925

-40

80,941

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the exercise of stock options

3,350

4,185

2,302

978

0

93

16

131

19

15

93

39

6

34

298

498

211

288

291

33

308

181

121

23

158

94

114

93

460

24

16

Proceeds from stock purchases under employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

78,167

Net cash provided by financing activities

192,275

4,239

83,139

1,001

4,556

140

-76

219

20

103

-15

174

6

204

241

606

207

102,385

291

33

308

181

121

23

158

-13,449

114

93

65,824

-1,312

81,775

Effect of exchange rate

-

-

-

-

-

-

-

-

-

-

-

-0

0

-1

0

-4

-5

-29

0

11

3

-21

0

-1

1

-1

2

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

71,272

-

-

-

2,432

-3,504

8,144

-13,568

24,725

-15,583

2,979

-1,202

-16,294

-3,038

17,003

-1,286

-19,992

1,601

-12,970

28,183

2,035

-2,731

-29,924

-35,178

40,479

-5,288

36,918

16,505

-3,655